Sign In
Buy NE
$46.65
-0.480 (-1.02%)
At Close: Jun 03, 2026
HOUSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation ("Great Lakes" or the “Company”) (NASDAQ: GLDD), the largest provider of dredging services in the United States,
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
09:00am, Tuesday, 26'th Nov 2024
ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chai
SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024
08:00am, Tuesday, 26'th Nov 2024
DENVER, Nov. 26, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hy
Direct Digital Holdings to Participate in Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference
09:00am, Monday, 25'th Nov 2024
HOUSTON , Nov. 25, 2024 /PRNewswire/ -- Direct Digital Holdings, Inc. (Nasdaq: DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating thr
Snail, Inc. to Participate in Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference
09:00am, Friday, 22'nd Nov 2024
CULVER CITY, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or “the Company”), a leading, global independent developer and publisher of interactive digital
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
08:30am, Thursday, 21'st Nov 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pione
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference
08:30am, Thursday, 21'st Nov 2024
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive te
Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
08:30am, Wednesday, 20'th Nov 2024
GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven ca
Post-Election Insider Buying in These 6 Stocks Is Huge
08:15am, Sunday, 17'th Nov 2024
24/7 Wall St. Insights As we race toward the end of the year, the past week brought some huge insider share purchases.
Noble Roman's Announces Third Quarter 2024 Financial Data
04:00pm, Wednesday, 13'th Nov 2024
INDIANAPOLIS, IN / ACCESSWIRE / November 13, 2024 / Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub ("CPP"),
Noble Roman's to Release 3rd Quarter 2024 Financial Data on November 13th; to Host Conference Call on November 14th at 4:00 PM EST
09:00am, Wednesday, 13'th Nov 2024
INDIANAPOLIS, IN / ACCESSWIRE / November 13, 2024 / Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub, announc
Noble Capital Markets Initiates Equity Research Coverage on Zomedica
06:30am, Tuesday, 12'th Nov 2024
ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion an
Graham price target raised to $45 from $35 at Noble Capital
08:57am, Monday, 11'th Nov 2024
Noble Capital raised the firm's price target on Graham to $45 from $35 and keeps an Outperform rating on the shares. Graham's Q2 results exceeded expectations as "strong" sales growth, along with "exc
Noble Corporation: Production Backlog And Capital Return Promising, Yet Low Visibility On Earnings Past 2025
03:11am, Friday, 08'th Nov 2024
Noble Corporation's geographic diversification and strong client base are positives, but its lack of long-term contracts and idle rigs are concerning. The company's fluctuating revenues and earnings,
Noble Corporation plc (NE) Q3 2024 Earnings Call Transcript
11:05am, Wednesday, 06'th Nov 2024
Noble Corporation plc (NYSE:NE ) Q3 2024 Earnings Conference Call November 6, 2024 9:00 AM ET Company Participants Ian MacPherson - Vice President of Investor Relations Robert Eifler - President and C
